Severe side effects of Invokana – part of a new class of diabetes drugs manufactured by J&J – have prompted a wave of litigation filed throughout the United States. Most of the Invokana lawsuits have been centralized in New Jersey federal court under MDL # 2750 for more efficient pretrial... Read more »

In a case management order filed by US District Judge Matthew F. Kennelly, Androgel maker AbbVie was denied its attempt to have the first bellwether case dismissed on grounds that the statute of limitations had expired. The testosterone lawsuit, filed by Jeffrey Konrad, was originally selected as a representative case... Read more »

The makers of Farxiga, Bristol-Myers Squibb and AstraZeneca, are facing at least 18 product liability lawsuits filed in federal courts. These have now been centralized into a multidistrict litigation (MDL) pursuant to an order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued on April 6, 2017. The... Read more »

In mid-January, the first steps in the Invokana multidistrict litigation (MDL) began. U.S. District Judge Brian Martinotti, who is presiding over the MDL in the District of New Jersey, announced 1) the pending appointment of a special mediator to deal with discovery issues and settlement possibilities and 2) a “science... Read more »

Earlier in October, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a consolidation order for Taxotere lawsuits filed in federal courts around the country. The claims will now proceed in a multidistrict litigation (MDL) against defendant Sanofi-Aventis. The ruling affects at least 33 cases that had been pending in 16 different U.S.... Read more »

Eight Androgel lawsuits have been selected out of around 5,500 cases currently pending to serve as bellwether trials in the coordinated litigation. The bellwether trials are carefully selected to provide insight into how juries might respond to evidence and testimony in future trials. These early trials also can serve as... Read more »

Fresenius Medical Care North America agreed to a $250 million settlement to resolve lawsuits that claim the company was aware of risks of their dialysis products yet failed to warn the public. The litigation centers upon Granuflo and Naturalyte, two dialysates that have been blamed for heart problems, strokes and death... Read more »

The Xarelto multidistrict litigation in Louisiana continues to grow, as another lawsuit was added to the ongoing proceedings on February 11. Estella Roethler filed a lawsuit individually and as the representative of the estate of Augustina Asocar Rodriguez. Rodriguez was prescribed and ingested the blood thinning medication from approximately January... Read more »

An Arlington, Texas man has filed a testosterone lawsuit against Endo Pharmaceuticals, Inc., Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline, LLC. His lawsuit will join the multidistrict litigation in the Northern District of Illinois. According to his short form complaint, the man was prescribed and began taking Testim in June 2010. In... Read more »

A recent complaint was filed in the United States District Court for the District of Massachusetts, where it joins the Zofran (Ondansetron) Products Liability Litigation known as MDL 2657. The case centers upon allegations that drug maker GlaxoSmithKline (GSK) negligently marketed its powerful anti-nausea drug to pregnant women without providing... Read more »